Hemastatx GmbH
Biotechnology · Allschwil, Basel-Landschaft
Hemastatx GmbH is a Swiss biotechnology company based in Allschwil, Canton of Basel-Landschaft, listed in the Swiss commercial register since 2025 (UID CHE-249.117.584).
Board members & signatories
- Karen Vanhoorelbeke — Geschäftsführer
- Pauline-Sue Pfirter — Geschäftsführer
- Kevin Hollevoet — Gesellschafter
Registered purpose
Die Gesellschaft bezweckt die Erforschung, die Entwicklung, die Herstellung, die Verwertung, der Erwerb und den Vertrieb von pharmazeutischen und diagnostischen Produkten und Technologien. Die Gesellschaft kann alle Geschäfte tätigen und Massnahmen ergreifen, die geeignet sind, den Gesellschaftszweck direkt oder indirekt zu fördern, wie beispielsweise im In- und Ausland Unternehmungen aller Art, G…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What Hemastatx does
OFFERING
Hemastatx develops targeted therapies for severe bleeding disorders, with its lead program HMX-001 being a proprietary monoclonal antibody designed to prevent bleeding in patients with von Willebrand factor (VWF)-related disorders. The therapy targets the enzyme ADAMTS13 to modulate its activity and preserve functional high-molecular-weight VWF, thereby preventing severe bleeding episodes.
Unlock the full analysis →Similar companies
- HemostOD AG — Biotechnology · Saint-Sulpice
- ADC Therapeutics AG — Biotechnology · Epalinges
- Topadur Pharma AG — Pharmaceuticals · Schlieren
- MedXCell SA — Biotechnology · Montreux
- Numab Therapeutics AG — Biotechnology · Horgen
- Qanatpharma AG — Biotechnology · Stans
Find every biotechnology company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned biotechnology companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime